GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT)
|
|
|
- CAS-Nr.
- 112188-16-6
- Englisch Name:
- GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT)
- Synonyma:
- Gd-DO 3A;Gadobutrol Impurity 100;Gadolinium Butanol Impurity 7;Gadolinium alcohol impurity C;Cilipride Tartrate Impurity J;Gadoteridol Related CoMpound B;Des(2-Hydroxypropyl) Gadoteridol;Gadobutrol EP Impurity C (Gadoteridol USP Related Compound B); gadolinium(III) 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid;1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid gadolinium complex
- CBNumber:
- CB5500505
- Summenformel:
- C14H22GdN4O6
- Molgewicht:
- 499.6
- MOL-Datei:
- 112188-16-6.mol
|
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) Eigenschaften
- Schmelzpunkt:
- >300°C
- storage temp.
- Hygroscopic, Refrigerator, under inert atmosphere
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- Farbe
- White to Off-White
- Stabilit?t:
- Hygroscopic
- InChI
- InChI=1S/C14H25N4O6.Gd/c19-12(20)9-16-3-1-15-2-4-17(10-13(21)22)6-8-18(7-5-16)11-14(23)24;/h1-11H2,(H,19,20)(H,21,22)(H,23,24);/q-1;+4/p-3
- InChIKey
- ADBHHYXJOIUPRL-UHFFFAOYSA-K
- SMILES
- O=C1CN23CCN45CCN6CCN7(CC2)CC(=O)[O-][Gd+3]3476([O-]C(=O)C5)[O-]1
Sicherheit
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Des(2-hydroxypropyl) Gadoteridol is a contrast imaging agent metabolite from Gadoteridol (G125900), used as an MRI contrast chelating agent.
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 52)Lieferanten
- Gadolinium, [1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7]-
- Gd-DO 3A
- GADOTERIDOL RELATED COMPOUND B (50 MG) (1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID, MONOGADOLINIUM SALT)
- Gadoteridol Related Compound B (50 mg) (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt)
- Des(2-Hydroxypropyl) Gadoteridol
- Gadoteridol Related CoMpound B
- 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid gadolinium complex
- gadolinium(III) 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
- 2-[4,7-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate:gadolinium(3+)
- Gadoteridol Related Compound B (1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium (1287653)
- Gadobutrol Impurity 100
- Gadolinium Butanol Impurity 7
- 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, gadolinium complex (Gadobutrol Impurity)
- Gadobutrol EP Impurity C (Gadoteridol USP Related Compound B)
- Gadolinium alcohol impurity C
- Cilipride Tartrate Impurity J
- 112188-16-6
- C14H23GdN4O6
